Polymers Enhancing Bioavailability in Drug Delivery, 2nd Edition
This Special Issue provides an update on the state of the art and current trends in polymeric drug delivery systems specifically designed for improving drug bioavailability. The multiple contributions received further strengthen the role of polymers in modern drug delivery and targeting, illustratin...
Saved in:
| Other Authors: | |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_132449 | ||
| 005 | 20240108 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20240108s2023 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-9556-6 | ||
| 020 | |a 9783036595573 | ||
| 020 | |a 9783036595566 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-9556-6 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a GP |2 bicssc | |
| 072 | 7 | |a PS |2 bicssc | |
| 072 | 7 | |a PSB |2 bicssc | |
| 100 | 1 | |a Fernandes, Ana Isabel |4 edt | |
| 700 | 1 | |a Fernandes, Ana Isabel |4 oth | |
| 245 | 1 | 0 | |a Polymers Enhancing Bioavailability in Drug Delivery, 2nd Edition |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
| 300 | |a 1 electronic resource (286 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a This Special Issue provides an update on the state of the art and current trends in polymeric drug delivery systems specifically designed for improving drug bioavailability. The multiple contributions received further strengthen the role of polymers in modern drug delivery and targeting, illustrating the different approaches possible and unveiling what the future may bring. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Research & information: general |2 bicssc | |
| 650 | 7 | |a Biology, life sciences |2 bicssc | |
| 650 | 7 | |a Biochemistry |2 bicssc | |
| 653 | |a Histoplasma capsulatum | ||
| 653 | |a PLGA | ||
| 653 | |a Itraconazole | ||
| 653 | |a macrophage | ||
| 653 | |a functionalized nanoparticle | ||
| 653 | |a F4/80 receptor | ||
| 653 | |a rutin | ||
| 653 | |a nanocrystals | ||
| 653 | |a anti-inflammatory | ||
| 653 | |a hydroxypropyl beta-cyclodextrin | ||
| 653 | |a nanoparticles | ||
| 653 | |a budesonide | ||
| 653 | |a chitosan | ||
| 653 | |a colon delivery | ||
| 653 | |a eudragit | ||
| 653 | |a pellets | ||
| 653 | |a ferrisilicate | ||
| 653 | |a PEG | ||
| 653 | |a insulin | ||
| 653 | |a encapsulation | ||
| 653 | |a diabetic mellitus | ||
| 653 | |a polypeptides | ||
| 653 | |a drug delivery | ||
| 653 | |a doxorubicin | ||
| 653 | |a cancer | ||
| 653 | |a topology of poly-l-cystein | ||
| 653 | |a antimicrobial | ||
| 653 | |a antifouling | ||
| 653 | |a pH sensitivity | ||
| 653 | |a zwitterionic polymers | ||
| 653 | |a gamma radiation | ||
| 653 | |a copolyester | ||
| 653 | |a SPION | ||
| 653 | |a cysteine | ||
| 653 | |a bioconjugation | ||
| 653 | |a and enzymatic release | ||
| 653 | |a polymeric nanoparticles | ||
| 653 | |a drug delivery and targeting | ||
| 653 | |a ocular posterior segment | ||
| 653 | |a oxidative stress | ||
| 653 | |a retinal degeneration | ||
| 653 | |a nerve growth factor | ||
| 653 | |a peanut agglutinin | ||
| 653 | |a zebrafish | ||
| 653 | |a molecular dynamics simulation | ||
| 653 | |a interaction energy | ||
| 653 | |a hydrogen bonding | ||
| 653 | |a solid dispersion | ||
| 653 | |a hot melt extrusion | ||
| 653 | |a amorphous formulation | ||
| 653 | |a tacrolimus | ||
| 653 | |a sucrose acetate isobutyrate | ||
| 653 | |a amorphous solid dispersion | ||
| 653 | |a dissolution | ||
| 653 | |a stability | ||
| 653 | |a pharmacokinetics | ||
| 653 | |a phytomedicine | ||
| 653 | |a nanosponges | ||
| 653 | |a lactoferrin | ||
| 653 | |a bioavailability | ||
| 653 | |a MDA-MB-231 cells | ||
| 653 | |a caspase-3 | ||
| 653 | |a cyclin-D1 | ||
| 653 | |a dendrimers | ||
| 653 | |a Janus nanoparticles | ||
| 653 | |a biocompatibility | ||
| 653 | |a nanoformulation | ||
| 653 | |a pharmaceuticals | ||
| 653 | |a 3D printing | ||
| 653 | |a hybrid scaffold | ||
| 653 | |a polycaprolactone | ||
| 653 | |a vancomycin | ||
| 653 | |a mesenchymal stem cells | ||
| 653 | |a tissue engineering | ||
| 653 | |a drug delivery systems (DDSs) | ||
| 653 | |a osteomyelitis | ||
| 653 | |a n/a | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/8489 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/132449 |7 0 |z DOAB: description of the publication |